CLAY B. SIEGALL - 21 Nov 2024 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
President and CEO, Director
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
21 Nov 2024
Net transactions value
+$962,181
Form type
4
Filing time
25 Nov 2024, 08:41:00 UTC
Previous filing
13 Aug 2024
Next filing
03 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $630,263 +66,057 +16% $9.54 485,693 21 Nov 2024 Direct F1
transaction IMNM Common Stock Purchase $331,918 +33,943 +7% $9.78 519,636 22 Nov 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction report was $9.5412, and the range of prices were between $9.41 and 9.68. Upon request be the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 The weighted average purchase price for the transaction report was $9.7787, and the range of prices were between $9.41 and $9.90. Upon request be the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.